Vir Biotechnology
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (22)
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
Started: 7/30/2025
A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection
Started: 3/12/2025
Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19.
Started: 6/10/2021
Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection
Started: 7/3/2020
A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection
Started: 8/5/2025
Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection
Started: 7/11/2021
SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.
Started: 9/17/2022
A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A
Started: 10/30/2022
Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19
Started: 2/18/2021
VIR-7831 for the Early Treatment of COVID-19 in Outpatients
Started: 8/27/2020
Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Started: 7/22/2025
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Started: 8/10/2023
To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
Started: 4/13/2022
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
Started: 9/21/2022
A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection
Started: 5/10/2023
A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218
Started: 6/1/2023
Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection
Started: 5/26/2020
Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)
Started: 3/28/2022
A Study to Investigate the PK, Safety, and Tolerability of Sotrovimab vs Placebo Administered IV or IM in Japanese and Caucasian Participants
Started: 7/6/2021
VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers
Started: 12/28/2020
Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B
Started: 11/14/2018